A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2002
11/20/2002	EP1187832B1 Amino heterocycles useful as pharmaceutical agents
11/20/2002	EP1107732B1 Oral liquid mucoadhesive compositions
11/20/2002	EP1054666B1 Liquid pharmaceutical formulation containing zotepine
11/20/2002	EP1047688B1 Thiophene nitrone compounds
11/20/2002	EP1007522B1 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, its preparation and therapeutic use
11/20/2002	EP0984952B1 A new salt
11/20/2002	EP0954337B1 Intestinal absorption of nicotine to treat nicotine responsive conditions
11/20/2002	EP0920422B1 Crytalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
11/20/2002	EP0826673B1 Acetamide derivatives, process for producing the same, and medicinal composition containing the same
11/20/2002	EP0752865B1 Use of substituted dextrane for treating nervous system damage, and heparane sulphate-enriched fractions
11/20/2002	EP0750507B1 Proteasome regulation of nf-kappa-b activity
11/20/2002	EP0699199B1 Heteroatom substituted alkyl benzylaminoquinuclidines as substance p antagonists
11/20/2002	CN1380884A Novel recombinant antibodies, amino acid sequences of CDR thereof and genes encoding the same
11/20/2002	CN1380883A Novel derivatives and analogues of galanthamin
11/20/2002	CN1380287A 2-acryl-3-substituted indoacetamide derivative and its medical application
11/20/2002	CN1380071A Chinese medicine for curing psychosis and epilepsy
11/20/2002	CN1380057A New application of ketamine, its preparation and new method for application
11/20/2002	CN1094491C 2-{4-[4-(4,5-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and use thereof
11/20/2002	CN1094486C Benzal compound and preparation method
11/20/2002	CN1094370C Prescription and method for preparing medicine to cure toothche and odontopathy
11/20/2002	CN1094369C Chinese medicinal herbs extractive and its application
11/20/2002	CN1094354C Nafiverine injection
11/20/2002	CN1094349C Pharmaceutical composition
11/20/2002	CN1094326C Carotenoid preparation having mixture of beta-carotene, ycopene and xanthophyll
11/19/2002	US6482848 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/19/2002	US6482838 Cholinesterase inhibitor
11/19/2002	US6482836 CRF antagonistic quino- and quinazolines
11/19/2002	US6482832 Heterocyclically substituted amides, their production and their use
11/19/2002	US6482830 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
11/19/2002	US6482829 Central nervous system disorders; heeadaches, antiinflammatory agents
11/19/2002	US6482824 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists
11/19/2002	US6482822 N-(iminomethyl)amines derivatives, their preparation, their use as medicines and compositions containing them
11/19/2002	US6482819 2,3-benzodiazepine derivatives
11/19/2002	US6482812 Method of locking 1α-OH of vitamin D compounds in axial orientation
11/19/2002	US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002	US6482517 Coated particles, methods of making and using
11/19/2002	US6482437 Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations
11/19/2002	US6482429 Stable powder inhalation dosage formulation
11/19/2002	US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites
11/19/2002	CA2272990C Heptapeptide oxytocin analogues
11/19/2002	CA2225780C New derivatives of n-benzylpiperazine, their preparation process and the pharmaceutical compositions they contain
11/19/2002	CA2112061C Alkyl substituted heterocyclic compounds
11/18/2002	WO2001087855A1 Triazole derivatives
11/18/2002	CA2381637A1 Compositions and methods for treating or preventing convulsions or seizures
11/14/2002	WO2002090974A2 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002	WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002	WO2002090553A2 Recombinant fusion proteins and the trimers thereof
11/14/2002	WO2002090532A1 Novel mutation
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090524A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002	WO2002090385A1 Protein polymer having unfold activity on higher-order structure of protein
11/14/2002	WO2002090375A2 Liver x receptor agonists
11/14/2002	WO2002090362A1 Azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene as 5-ht1a antagonists
11/14/2002	WO2002090359A1 Glucuronide adduct as gaba ligand
11/14/2002	WO2002090356A2 Method for the production of zolpidem
11/14/2002	WO2002090355A1 N-aroyl cyclic amines
11/14/2002	WO2002090353A1 Sulfonamides
11/14/2002	WO2002090349A1 N-oxide anthranylamide derivatives and their use as medicaments
11/14/2002	WO2002090348A1 Sulfonamides
11/14/2002	WO2002090346A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002	WO2002090337A1 Sulfonamides
11/14/2002	WO2002090333A1 Novel pyridinone and related heterocyclic derivatives
11/14/2002	WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002	WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090326A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
11/14/2002	WO2002090318A1 Process for preparing bicyclic amino acids
11/14/2002	WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002089858A1 Azo compounds for type i phototherapy
11/14/2002	WO2002089841A2 Method of preventing cell death using antibodies to neural thread proteins
11/14/2002	WO2002089814A1 17-METHYLENE-ANDROSTAN-3α-OL ANALOGS AS CRH INHIBITORS
11/14/2002	WO2002089811A1 Benzo[d]azepine derivatives as 5-ht6 receptor antagonists.
11/14/2002	WO2002089809A1 Medicinal uses of hydrazones and hydrazines
11/14/2002	WO2002089808A1 Novel use of 2-phenyl-substituted imidazotriazinones
11/14/2002	WO2002089806A1 Heterobicycles fkbp-ligands
11/14/2002	WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002	WO2002089798A2 Method and compositions for treating migraines
11/14/2002	WO2002089797A1 Treatment of adhd
11/14/2002	WO2002089794A1 Method for treating neuropathic pain and pharmaceutical preparation therefor
11/14/2002	WO2002089793A1 Sulfonamides
11/14/2002	WO2002089792A1 Sulfonamides
11/14/2002	WO2002089787A1 Potentiation of therapeutic effects of fatty acids
11/14/2002	WO2002089786A1 Compositions for improving mental concentration
11/14/2002	WO2002089785A1 Sulfonamides
11/14/2002	WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002	WO2002089779A2 Combined preparation for the prophylaxis and/or therapy of nerve cell and/or glia cell damage using a novel method of treatment
11/14/2002	WO2002089778A2 Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
11/14/2002	WO2002089777A1 Improved transdermal therapeutic system for the treatment of parkinson's disese
11/14/2002	WO2002089776A1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof
11/14/2002	WO2002089751A1 System and method for intranasal administration of lorazepam
11/14/2002	WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002	WO2002089740A2 Sulfonamides
11/14/2002	WO2002089738A2 Proteomimetic compounds and methods
11/14/2002	WO2002089736A2 Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment
11/14/2002	WO2002089729A2 Fused heterocyclic compounds
11/14/2002	WO2002076990A8 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
11/14/2002	WO2002076476A3 Prodrugs of anticancer agents employing substituted aromatic acids
11/14/2002	WO2002074764A3 Piperazine derivatives and their use as 5-ht1b ligands
11/14/2002	WO2002074326A3 Urocortin-iii and uses thereof

1 ... 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 ... 1833